Understanding Combination Therapy With Biologics and Immunosuppressives for the Treatment of Crohn's Disease

Por Colombel, Jean-Frederic
Publicado em 2010

When Should Combination Therapy for Patients with Crohn's Disease Be Discontinued?

Por Colombel, Jean-Frédéric
Publicado em 2012

Measuring Disability in IBD: The IBD Disability Index

Por Colombel, Jean-Frédéric
Publicado em 2013

Targeting the Preclinical Phase of Inflammatory Bowel Disease

Por Colombel, Jean-Frédéric
Publicado no Gastroenterol Hepatol (N Y) (2015)

The CHARM Trial of Adalimumab in Crohn’s Disease

Por Colombel, Jean-Frédéric
Publicado no Gastroenterol Hepatol (N Y) (2006)

Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention

Por Colombel, Jean-Frédéric
Publicado no Inflamm Bowel Dis (2018)

Anti-TNF Withdrawal in Inflammatory Bowel Disease

Por Torres, Joana, Cravo, Marília, Colombel, Jean-Frédéric
Publicado no GE Port J Gastroenterol (2016)

Functional gastrointestinal symptoms in patients with inflammatory bowel disease: A clinical challenge

Por Colombel, Jean-Frederic, Shin, Andrea, Gibson, Peter R.
Publicado no Clin Gastroenterol Hepatol (2018)

Colonic Pseudopolyps Resulting in Iron Deficiency Anemia

Por Hirten, Robert, Cohen, Benjamin L., Colombel, Jean-Frederic
Publicado no Clin Gastroenterol Hepatol (2017)

A New Blood Biomarker of Endoscopic Disease Activity: A Step Forward in the Treat-to-Target Paradigm for Crohn’s Disease?

Por AGRAWAL, MANASI, UNGARO, RYAN C., COLOMBEL, JEAN-FREDERIC
Publicado no Gastroenterology (2019)

The Role of Early Biologic Therapy in Inflammatory Bowel Disease

Por Berg, Dana Rachel, Colombel, Jean-Frederic, Ungaro, Ryan
Publicado no Inflamm Bowel Dis (2019)

JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications

Por Agrawal, Manasi, Kim, Eun Soo, Colombel, Jean-Frederic
Publicado no J Crohns Colitis (2020)

Targeting B cells for inflammatory bowel disease treatment: back to the future

Por Castro-Dopico, Tomas, Colombel, Jean-Frederic, Mehandru, Saurabh
Publicado no Curr Opin Pharmacol (2020)

Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer

Por Adenis, Antoine, Vanseymortier, Luc, Foissey, David, Colombel, Jean‐Frédéric
Publicado em 2007

Identifying strains that contribute to complex diseases through the study of microbial inheritance

Por Faith, Jeremiah J., Colombel, Jean-Frédéric, Gordon, Jeffrey I.
Publicado no Proc Natl Acad Sci U S A (2015)

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

Por Roda, Giulia, Jharap, Bindia, Neeraj, Narula, Colombel, Jean-Frederic
Publicado no Clin Transl Gastroenterol (2016)

The current state of the art for biological therapies and new small molecules in inflammatory bowel disease

Por Paramsothy, Sudarshan, Rosenstein, Adam K., Mehandru, Saurabh, Colombel, Jean-Frederic
Publicado no Mucosal Immunol (2018)

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review

Por Ungaro, Ryan, Colombel, Jean-Frédéric, Lissoos, Trevor, Peyrin-Biroulet, Laurent
Publicado no Am J Gastroenterol (2019)

What Should Gastroenterologists and Patients Know About COVID-19?

Por Ungaro, Ryan C., Sullivan, Timothy, Colombel, Jean-Frederic, Patel, Gopi
Publicado no Clin Gastroenterol Hepatol (2020)

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions

Por Ungaro, Ryan C., Kappelman, Michael D., Rubin, David T., Colombel, Jean-Frederic
Publicado no Gastroenterology (2021)